Seeing Is Believing
Currently out of the existing stock ratings of Adam Walsh, 61 are a BUY (89.71%), 7 are a HOLD (10.29%).
Analyst Adam Walsh, currently employed carries an average stock price target met ratio of 67% that have a potential upside of 39.91% achieved within 208 days. Previously, Adam Walsh worked at STIFEL.
Adam Walsh’s has documented 132 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GLPG, Galapagos NV ADR at 10-Jul-2020.
Analyst best performing recommendations are on VRTX (VERTEX PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) at 7/18/2017. The price target of $154 was fulfilled within 1 day with a profit of $21.84 (16.53%) receiving and performance score of 165.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$17
1 years 8 months 15 days ago
0/1 (0%)
$10.12 (147.09%)
Buy
$25
1 years 8 months 16 days ago
0/6 (0%)
$18.01 (257.65%)
Buy
$17
$8.63 (103.11%)
$17
2 years 4 months 12 days ago
1/6 (16.67%)
$12.9 (314.63%)
115
Buy
$15
2 years 10 months 23 days ago
0/1 (0%)
$7.49 (99.73%)
Buy
$9
$0.63 (7.53%)
$13
3 years ago
3/10 (30%)
$6.03 (203.03%)
392
What Year was the first public recommendation made by Adam Walsh?